PHP26- THE POTENTIAL BENEFITS AND DRAWBACKS OF ALLOWING DIRECT-TO-CONSUMER ADVERTISING OF PHARMACEUTICALS IN EUROPE
Sep 1, 2001, 00:00 AM
10.1016/S1098-3015(11)71687-4
https://www.valueinhealthjournal.com/article/S1098-3015(11)71687-4/fulltext
Section Title :
Section Order :
201
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)71687-4&doi=10.1016/S1098-3015(11)71687-4